Abstract
Breast cancer stem cells (BCSCs) are thought to be responsible for tumor initiation, metastasis and relapse. Our group and others have described markers useful in isolating BCSCs just as aldehyde dehydrogenase positive (ALDH+) or CD24-CD44+. In fact, cells which simultaneously express both sets of markers have the highest tumor initiating capacity. Although the transcriptomic profile of cells expressing each BCSC marker alone has been reported, the profile of the most tumorigenic population expressing both sets of markers has not. Here we used the biomarker combination of ALDH and CD24/CD44 to sort four populations isolated from triple-negative breast cancer (TNBC) patient-derived xenografts, and performed whole-transcriptome sequencing on each population. We systematically compared the profiles of the three states of BCSCs (ALDH+CD24-CD44+, ALDH+non-CD24-CD44+ and ALDH-CD24-CD44+) to that of the differentiated tumor cells (ALDH-non-CD24-CD44+). For the first time, we compared the ALDH+CD24-CD44+ BCSCs with the other two BCSC populations. In ALDH+CD24-CD44+ BCSCs, we identified P4HA2, PTGR1 and RAB40B as potential prognostic markers, which were virtually related to the status of BCSCs and tumor growth in TNBC cells.
References
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Mar 29, 2008·Cell Stem Cell·Christophe GinestierGabriela Dontu
Feb 5, 2009·Cancer Research·Emmanuelle Charafe-JauffretMax S Wicha
Dec 19, 2009·Breast Cancer Research and Treatment·Balazs GyörffyZoltan Szallasi
Jan 13, 2012·Nature Reviews. Cancer·Long V NguyenConnie J Eaves
Nov 6, 2012·Breast Cancer Research and Treatment·L MalorniG Arpino
Sep 26, 2013·Nature Reviews. Cancer·Benjamin Beck, Cédric Blanpain
Feb 11, 2014·Stem Cell Reports·Suling LiuMax S Wicha
Sep 30, 2015·Nature·Devon A LawsonZena Werb
Oct 19, 2016·Nature Reviews. Clinical Oncology·Giampaolo BianchiniLuca Gianni
Citations
May 8, 2018·Biomedicines·Toni Celià-Terrassa
Jul 19, 2018·Biomedicines·Judy S Crabtree, Lucio Miele
Oct 4, 2018·Current Stem Cell Research & Therapy·Payam ZarrintajMohammad Reza Saeb
Nov 16, 2019·Epigenomics·Xiaofeng DaiFengfeng Zhou
Jul 26, 2019·Artificial Cells, Nanomedicine, and Biotechnology·Chao HuangCungang Wu
Jan 11, 2020·Advanced Science·Lixing ZhangSuling Liu
Aug 8, 2020·Frontiers in Molecular Biosciences·Esta SterneckKuppusamy Balamurugan
Sep 21, 2018·Cancer Communications·Mengying TongQuentin Liu
May 17, 2019·Journal of Immunology Research·Isela Martínez-RezaRocío García-Becerra
Mar 21, 2019·Cancer Informatics·Zhonglin QuDaniel R Catchpoole
Feb 29, 2020·World Journal of Stem Cells·Jie BaiZun-Yi Wang
Sep 27, 2019·Frontiers in Oncology·Jiaojiao ZhouYiding Chen
Jul 28, 2020·Advanced Science·Lina ZhaoBaowei Jiao
Nov 20, 2018·Breast Cancer Research and Treatment·Jingjing LiuJin Zhang
May 31, 2020·Cell Biology and Toxicology·Fuchuang ZhangSuling Liu
Jan 24, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Wenyan FuShi Hu
Jan 29, 2021·Proceedings of the National Academy of Sciences of the United States of America·K J PientaR M Axelrod
Dec 18, 2020·Cancers·Xiaoli ZhangLang Li
Mar 7, 2021·International Journal of Molecular Sciences·Juliane StrietzJochen Maurer
Mar 7, 2021·Cancers·Chiara RomaniStefania Mitola
Mar 20, 2021·Seminars in Cancer Biology·Rui ZhangSuling Liu
May 18, 2021·The Journal of Cell Biology·Erik S LinklaterRytis Prekeris
Jun 18, 2021·Journal of the American Chemical Society·Julie M GarlickAnna K Mapp
Jul 27, 2021·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Kanakaraju ManupatiAmitava Das
Aug 4, 2021·Future Oncology·Hina QayoomManzoor A Mir
Aug 24, 2021·Frontiers in Pharmacology·Xing WangZufeng Guo
Oct 29, 2021·Advanced Science·Xupeng BaiYong Li